In vivo suppression of early experimental osteoarthritis by interleukin- 1 receptor antagonist using gene therapy

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1012-1019

  Pelletier, Jean Pierre ^a,c   Caron, John P ^a,b   Evans, Christopher ^c   Robbins, Paul D ^c   Georgescu, Helga I ^c   Jovanovic, Dragan ^a   Fernandes, Julio C ^a   Martel Pelletier, Johanne ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE MATRIX; CONTROLLED STUDY; DOG; DRUG EFFECT; GENE THERAPY; GENE TRANSFER; IMMUNOSUPPRESSIVE TREATMENT; INTRAARTICULAR DRUG ADMINISTRATION; MONOLAYER CULTURE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIUM;

ANIMALS; CARTILAGE; DOGS; FIBROBLASTS; GENE THERAPY; HUMANS; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LAC OPERON; OSTEOARTHRITIS; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; SYNOVIAL MEMBRANE; TRANSDUCTION, GENETIC;

EID: 0030961873     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400604     Document Type: Article

References (30)

1. Pelletier J-P, Martel-Pelletier J, Howell DS: Etiopathogenesis of osteoarthritis. In, Arthritis and Allied Conditions: A Textbook of Rheumatology. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea and Febiger, 1996
2. Pelletier J-P, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 19:545-568, 1993
3. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 48:645-653, 1989
4. Pelletier J-P, McCollum R, Cloutier JM, Martel-Pelletier J: Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 22 (Suppl 43):109-114, 1995
5. Sadouk M, Pelletier J-P, Tardif G, Kiansa K, Cloutier JM, Martel-Pelletier J: Human synovial fibroblasts coexpress interleukin-l receptor type I and type II mRNA: the increased level of the interleukin-1 receptor in osteoarthritic cells is related to an increased level of the type 1 receptor. Lab Invest 73:347-355, 1995
6. Martel-Pelletier J, McCollum R, DiBattista JA, Faure M-P, Chin JA, Fournier S, Sarfati M, Pelletier J-P: The interleukin-1 receptor in normal and osteoathritic human articular chondrocytes: identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 35:530-540, 1992
7. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149:1054-1062, 1992
8. Pelletier J-P, Mineau F, Ranger P, Tardif G, Martel-Pelletier J: The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4:77-84, 1996
9. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995
10. Arner EC, Harris RR, DiMeo TM, Collins RC, Galbraith W: Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. J Rheumatol 22:1338-1346, 1995
11. Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 54: 167-227, 1993
12. Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Harman JW, Roessler BJ: Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 96:2454-2460, 1995
13. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier J-P: Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 39:1535-1544, 1996
14. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M, and the IL-1Ra Arthritis Study Group: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 39:1092-1101, 1996
15. Evans CH, Robbins PD: Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 8:230-234, 1996
16. Evans CH, Robbins PD: Gene therapy for arthritis. In, Gene Therapeutics: Methods and Applications of Direct Gene Transfer. Edited by JA Wolff. Boston, Birkhauser, 1994
17. Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH: Gene transfer to synoviocytes: prospects for gene treatment for arthritis. DNA Cell Biol 11:227-231, 1992
18. Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J: Intraarticular injections with methyl-prednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 37:414-423, 1994
19. Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH: Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764-10768, 1993
20. Mankin HJ, Dorfman H, Lippiello L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523-537, 1971
21. Pelletier J-P, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr: Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 28:554-561, 1985
22. Nita I, Ghivizzani SC, Galea-Lauri J, Bandara G, Georgescu HI, Robbins PD, Evans CH: Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 39:820-828, 1996
23. Hung GL, Galea-Lauri J, Mueller GM, Georgescu HI, Larkin LA, Suchanek MK, Tindal MH, Robbins PD, Evans CH: Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1:64-69, 1994
24. Makarov SS, Olsen JC, Johnston WN, Schwab JH, Anderle SK, Brown RR, Haskill JS: Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats. Gene Ther 2:424-428, 1995
25. Makarov SS, Olsen CC, Johnston WN, Anderle SK, Brown RR, Baldwin AS, Haskill JS, Schwab JH: Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc Natl Acad Sci U S A 93:402-406, 1996
26. Otani K, Nita IM, Macaulay W, Georgescu HI, Robbins PD, Evans CH: Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 156:3558-3562, 1996
27. Evans CH, Robbins PD, Ghivizzani SC, Herndon JK, Kang R, Tommaino MM, Wasko MC, Watkins SC, Whiteside TK, Glorioso JC, Lotze MT, Wright TM: Clinical trial to assess the safety, feasibility and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7:1261-1280, 1996
28. Palmer TD, Rosman GJ, Osborne WR, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 88:1330-1334, 1996
29. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adcnovirus vectors. Nat Med 2:545-550, 1996
30. Kang R, Marui T, Ghivizzani SC, Nita IM, Georgeseu HI, Suh JK, Robbins PD, Evans CH: Ex vivo gene transfer to chondroeytes in full-thickness articular cartilage defects: a feasibility study. Ostcoarthritis Cartilage 5:139-143, 1997